BioSimilar FDA Final Guidance on Demonstrating Biosimilar Interchangeability Thomas Sullivan Jun 18, 2019 0 The FDA issued a final guidance on the pathway for interchangeable biosimilar drugs. The guidance is intended to assist sponsors…
